AbbVie Ordered To Pay $3M In AndroGel Retrial
An Illinois federal jury on Monday found AbbVie Inc.'s AndroGel product caused an Oregon man's heart attack and ordered the company to pay him more than $3 million, a verdict that came...To view the full article, register now.
Already a subscriber? Click here to view full article